Results 161 to 170 of about 42,251 (222)

DDX41-Mutated AML: A Case Report and Perspectives. [PDF]

JCO Precis Oncol
Yashar WM, Eide CA, Kurtz SE, Long N, Johnson KJ, Tognon CE, Druker BJ, Tyner JW, Swords R.   +8 more
europepmc   +1 more source

Studying clonal heterogeneity of acute myeloid leukemia under nutrient and chemotherapy stress. [PDF]

Blood Adv
Mayerhofer C, Crompton E, Mayerhofer E, Kristiansen T, Fukushima T, Keyes S, Sharda A, Li D, Da Silva C, Shrestha D, Kiem A, Feuchtinger T, Scadden DT, Miller PG.   +13 more
europepmc   +1 more source

Early Outcomes After Haploidentical Hematopoietic Cell Transplantation in Elderly Patients with Myeloid Malignancies in India: A Single Center Experience. [PDF]

Blood Cell Ther
Sinha Roy S, Potdar C, Vikrem B, Singh MK, Singh M, Chandra D, Rahman K, Gupta R, Kashyap R.   +8 more
europepmc   +1 more source

Intermediate doses cytarabine after induction with CPX-351 for patients with secondary AML: safety and efficacy. [PDF]

Ann Hematol
Perrone S, Corbingi A, Vetro C, Palumbo FE, Minetto P, Riva C, Cicconi L, Vernarecci C, Lemoli RM, Pulsoni A, Guolo F.   +10 more
europepmc   +1 more source

Diagnosis and management of rare acute erythroid leukemia with hemophagocytic lymphohistiocytosis: a case report. [PDF]

Front Oncol
Zhang Y, Tang G, Cheng H.
europepmc   +1 more source

R-CHOP and R-cytarabine for transplant-ineligible MCL. [PDF]

Blood Adv
Klener P, Tušková L, Blahovcová P, Trněný M.   +3 more
europepmc   +1 more source

Olive Leaf Extract (OLE) Anti-Tumor Activities Against Hematologic Tumors: Potential Therapeutic Implications for Pediatric Patients with B-Acute Lymphoblastic Leukemia. [PDF]

Nutrients
Airoldi I, Canè L, Brignole C, Ciampi E, Montagna D, Morandi F.   +5 more
europepmc   +1 more source

A phase I/II study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia: final analysis. [PDF]

Ther Adv Hematol
Sawa M, Miyamoto T, Kim HJ, Hiramatsu Y, Cheong JW, Ikezoe T, Naoe T, Akashi K, Morita S, Kosako M, Shimura M, Terada W, Kadokura T, Hill J, Miyawaki S, Gill SC, Heinloth A, Hasabou N.   +17 more
europepmc   +1 more source

Clinical characteristics, genomic profiling, treatments, and outcomes of Langerhans cell sarcoma. [PDF]

Orphanet J Rare Dis
Lang M, Zheng XJ, Chang L, Zhou DB, Zhang W, Cao XX.   +5 more
europepmc   +1 more source

In vitro drug sensitivity and clinical efficacy of the HAG regimen in pediatric AML. [PDF]

Oncologist
Shen D, Yan W, Xia T, Shang L, Zhang J.
europepmc   +1 more source